Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms

Novel oral anticoagulants (NOACs) are drugs approved for the prevention and treatment of many thromboembolic cardiovascular conditions as a safer alternative to warfarin. We reviewed studies published in PubMed<sup>®</sup>, UpToDate<sup>®</sup>, Web of Science<sup>®<...

Full description

Bibliographic Details
Main Authors: Angela Saviano, Mattia Brigida, Carmine Petruzziello, Marcello Candelli, Maurizio Gabrielli, Veronica Ojetti
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
novel oral anticoagulants
NOACs
gastrointestinal bleeding
edoxaban
apixaban
rivaroxaban
Online Access:https://www.mdpi.com/1422-0067/23/22/13955

Internet

https://www.mdpi.com/1422-0067/23/22/13955

Similar Items